• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Pharmaceuticals

Report finds pressure from Congress does not budge drug prices

November 18, 2016 By Sarah Faulkner

Capitol Hill

Committees in Congress have issued more than a dozen subpoenas to drug-makers for alleged price-hiking in the last 2 years, with members of the House and Senate collecting hundreds of thousands of documents on pricing strategies and marketing tactics. They’ve put pharmaceutical execs through more than 16 hours of public testimony. But an Associated Press review shows that pressure from Washington […]

Filed Under: Featured, Legal News, Pharmaceuticals, Wall Street Beat Tagged With: Mylan

DBV, BioNet-Asia study needle-free pertussis booster vaccination

November 17, 2016 By Sarah Faulkner

DBV Technologies (NSDQ:DBVT) and BioNet-Asia said today that the independent Data & Safety Monitoring Board positively reviewed DBV’s needle-free vaccine patch technology, Viaskin, and that enrollment in a Phase I trial for booster immunization against pertussis will continue into the 2nd dosing cohort. The Viaskin pertussis booster vaccination program will test the ability of DBV’s needle-free vaccine […]

Filed Under: Clinical Trials, Drug-Device Combinations, Featured, Pharmaceuticals, Respiratory Tagged With: BioNet-Asia, DBV Technologies

New drug capsule delivers medicine for weeks after swallowing

November 17, 2016 By Sarah Faulkner

New drug capsule delivers medicine for weeks after swallowing

Researchers from Massachusetts Institute of Technology, spurred by a challenge from Bill Gates, developed a star-shaped drug capsule that can gradually release medication and stay in the stomach for to 2 weeks after being swallowed. The study, published yesterday in Science Translational Medicine, described the team’s work using the capsule to deliver an anti-parasitic drug, invermectin, which […]

Filed Under: Featured, Pharmaceuticals, Research & Development Tagged With: Massachusetts Institute of Technology

Cumberland Pharma acquires U.S. rights to Nordic’s injectable methotrexate

November 16, 2016 By Sarah Faulkner

Cumberland Pharmaceuticals

Cumberland Pharmaceuticals (NSDQ:CPIX) said today that it acquired exclusive U.S. rights to Nordic Group‘s injectable methotrexate product line to treat rheumatoid arthritis, juvenile idiopathic arthritis, severe psoriatic arthritis, and severe disabling psoriasis. Nordic Group has registered the product line for patient use in European countries, so Cumberland will register and commercialize the products in the U.S. […]

Filed Under: Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Pharmaceuticals Tagged With: Cumberland Pharmaceuticals, Nordic Group

Injectable opioid dependence treatment succeeds in clinical trial

November 15, 2016 By Sarah Faulkner

Camurus, Braeburn Pharmaceuticals

Camarus AB (STO:CAMX) and Braeburn Pharmaceuticals said this week that a late-stage trial of its injectable opioid dependence treatment was successful. CMAX shares surged 16% at the beginning of the week following the announcement. The injectable buprenorphine therapy could be another treatment used to combat the growing opioid epidemic in the United States, which claimed the lives […]

Filed Under: Clinical Trials, Drug-Device Combinations, Featured, Implants, Pharmaceuticals Tagged With: Braeburn Pharmaceuticals, Camarus AB

China’s Uni-Bio Science, Luqa Pharmaceuticals ink deal for dermatology drug-device combos

November 15, 2016 By Sarah Faulkner

China's Uni-Bio Science, Luqa Pharmaceuticals ink deal for dermatology drug-device combos

Uni-Bio Science (HKG:0690) said today that it inked a strategic partnership with Luqa Pharmaceuticals for the marketing of dermatology drug-device combination products. According to the agreement, the China-based companies can co-promote drugs or medical devices for the treatment of dermatological disorders, including existing products. The 3-year promotion agreement, with an option to renew for 2 more years, enables […]

Filed Under: Drug-Device Combinations, Featured, Pharmaceuticals Tagged With: Luqa Pharmaceuticals, Uni-Bio Science

Light-driven motor powers nanorobot drug delivery system

November 15, 2016 By Sarah Faulkner

Light-driven motor powers nanorobot drug delivery system

Researchers proposed a nanosized, light-driven motor that is powerful enough to carry a certain load and possible act as a drug delivery system, according to the study published in the Journal of Chemical Physics.  “The unprecedented characteristics of dipole photomotors based on semiconductor nanoclusters offer the prospect of more than just addressing a certain scarcity of […]

Filed Under: Featured, Nanoparticles, Pharmaceuticals, Research & Development

Touch Surgery, Pacira to develop knee surgery sim

November 14, 2016 By Sarah Faulkner

Touch Surgery and Pacira Pharmaceuticals (NSDQ:PCRX) launched the Exparel knee training simulation for the Touch Surgery app, designed to provide clinicians with a virtual training experience for administering the bupivacaine liposome injectable suspension in total knee arthroplasty. The simulation includes a 3D environment where clinical decisions and viewpoints are all dictated by the user and simulates […]

Filed Under: Drug-Device Combinations, Featured, Pharmaceuticals, Surgical Tagged With: Pacira Pharmaceuticals, Touch Surgery

Dow subsidiary presents transdermal delivery system

November 10, 2016 By Sarah Faulkner

Dow (NYSE:DOW) subsidiary Dow Corning presented its latest drug delivery tech for transdermal therapies at the American Assn. of Pharmaceutical Sciences annual meeting. Dow Corning introduced its transdermal delivery patch, the SilAc Hybrid pressure-sensitive adhesive, which combine the properties of acrylic and silicone polymers. The Midland, Mich.-based company also featured its silicone-based topical ingredients with enhanced […]

Filed Under: Business/Financial News, Featured, Pharmaceuticals Tagged With: Dow Corning

Trump’s win boosts drug stocks

November 9, 2016 By Sarah Faulkner

Pharmaceutical stocks surged today after Donald Trump won the U.S. presidential election, as investors concluded the threat of action on drug pricing had lessened. California’s Proposition 61, which would have prevented the state of California from purchasing drugs from a manufacturer for a price higher than that paid by the U.S. Veterans Affairs Dept., failed to […]

Filed Under: Featured, Pharmaceuticals, Policy, Wall Street Beat Tagged With: Mylan, Novo Nordisk, Roche

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 202
  • Page 203
  • Page 204
  • Page 205
  • Page 206
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS